| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.852 | 6.519 | 8.427 | 11.284 | 12.831 | 12.510 | 13.077 | 14.897 | 13.699 | 13.205 |
| Total Income - EUR | 3.035 | 6.520 | 8.428 | 11.285 | 12.832 | 12.510 | 13.077 | 14.897 | 13.705 | 13.206 |
| Total Expenses - EUR | 11.730 | 9.804 | 11.361 | 14.086 | 8.661 | 8.282 | 9.286 | 9.807 | 10.725 | 12.457 |
| Gross Profit/Loss - EUR | -8.695 | -3.284 | -2.933 | -2.800 | 4.171 | 4.228 | 3.792 | 5.090 | 2.979 | 748 |
| Net Profit/Loss - EUR | -8.787 | -3.414 | -3.027 | -2.952 | 3.786 | 3.883 | 3.446 | 4.652 | 2.393 | 385 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Hipocrat Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 87 | 58 |
| Current Assets | 20.427 | 11.490 | 9.035 | 3.852 | 4.219 | 5.945 | 7.058 | 6.074 | 8.451 | 4.797 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.693 | 3.819 | 3.843 | 189 | 584 | 612 | 404 | 945 | 1.024 | 1.289 |
| Cash | 16.734 | 7.671 | 5.192 | 3.663 | 3.635 | 5.333 | 6.653 | 5.130 | 7.427 | 3.508 |
| Shareholders Funds | 17.553 | 6.946 | 3.801 | 780 | 3.836 | 5.476 | 6.679 | 4.836 | 7.214 | 3.188 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.874 | 4.545 | 5.234 | 3.072 | 382 | 469 | 379 | 1.239 | 1.324 | 1.667 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Hipocrat Med Srl